2024 – 2025 Influenza Seasonal and Other Vaccines

Nov 04, 2024

All vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) are covered by MaineCare pharmacy benefit without a member copayment, this includes influenza vaccines.

In preparation for the 2024-2025 Influenza (Flu) season, please review the MaineCare preferred vaccines listed below. These vaccines do not require Prior Authorization (PA). 

Influenza vaccines: 

• Afluria® (Trivalent)
• Fluarix® (Trivalent)
• FluLaval® (Trivalent)
• Fluzone® (Trivalent)

Based on ACIP recommendations, the following vaccines are preferred for members ≥ 65 years of age:

• Fluad® (Trivalent)
• Flublok® (Trivalent)
• Fluzone® (High-Dose Trivalent)

Additionally, the vaccines listed below are recommended by ACIP and covered as preferred by MaineCare’s pharmacy benefit without a member copayment. All vaccine products may be subject to age edits based on the vaccine’s labeled indication.

• Covid Vaccines - COMIRNATY, SPIKEVAX
• Hepatitis vaccines - ENGERIX-B, HAVRIX, RECOMBIVAX-HB, TWINRIX, VAQTA                 
• Herpes Zoster - SHINGRIX
• Meningococcus - MENACTRA, MENQUADFI, MENVEO
• Pneumococcal vaccines - PNEUMOVAX, PREVNAR, VAXNEUVANCE
• Rotavirus - ROTARIX, ROTATEQ
• RSV - AREXVY, ABRYSVO
• Tetanus-diphtheria - TENIVAC
• Tetanus-diphtheria - pertussis: ADACEL, BOOSTRIX, DAPTACEL, INFANRIX
• Other: ACTHIB, GARDASIL-9, M-M-R, QUADRACEL, VIVOTIF

For questions, please contact the Optum Pharmacy Help Desk at 1-888-420-9711. or by email at MaineHD@optum.com.